Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Luqa Pharma to Launch Italian Wound Healing Product in China

publication date: Mar 10, 2015
Luqa Pharmaceuticals, a Hong Kong in-licensing company, will begin a China launch of Ialuxid®, a non-antibiotic antimicrobial gel made by BMG Pharma S.r.l. of Italy. Ialuxid combines hyaluronic acid, hydrogen peroxide and glycine, forming a film to promote wound healing, especially surgical wounds, while fighting bacteria and inflammation. It has been approved as a medical device in Europe and China, and is under review in the US. Luqa in-licensed three products from BMG in 2013. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital